167 related articles for article (PubMed ID: 25578492)
1. Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer.
Guo X; Chen C; Liu B; Wu Y; Chen Y; Zhou X; Huang X; Li X; Yang H; Chen Z; Xing J
Tumour Biol; 2015 May; 36(5):3931-9. PubMed ID: 25578492
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer.
Fei F; Guo X; Chen Y; Liu X; Tu J; Xing J; Chen Z; Ji J; He X
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1095-102. PubMed ID: 25492048
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
4. Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival.
Eilertsen M; Andersen S; Al-Saad S; Kiselev Y; Donnem T; Stenvold H; Pettersen I; Al-Shibli K; Richardsen E; Busund LT; Bremnes RM
PLoS One; 2014; 9(9):e105038. PubMed ID: 25225794
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese.
Yang Y; Fei F; Song Y; Li X; Zhang Z; Fei Z; Su H; Wan S
Cancer Sci; 2014 Jan; 105(1):89-96. PubMed ID: 24304228
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in
He Y; Wang G; Wang Q; Zhao Z; Gan L; Yang S; Wang Y; Guo S; An J; Zhang J; Zhang Z; Zhou F
Future Oncol; 2021 Mar; 17(7):795-805. PubMed ID: 33541123
[No Abstract] [Full Text] [Related]
7. Genetic variations in SLC3A2/CD98 gene as prognosis predictors in non-small cell lung cancer.
Guo X; Li H; Fei F; Liu B; Li X; Yang H; Chen Z; Xing J
Mol Carcinog; 2015 Jun; 54 Suppl 1():E52-60. PubMed ID: 24782339
[TBL] [Abstract][Full Text] [Related]
8. Effect of thymidylate synthase gene polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer patients.
Dong H; Bao D; Guo X; Hu J; Li X; Wan S; Xing J
Tumour Biol; 2015 Sep; 36(9):7151-7. PubMed ID: 25877757
[TBL] [Abstract][Full Text] [Related]
9. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid synthesis pathway genetic variants and clinical outcome of non-small cell lung cancer patients after surgery.
Jin X; Zhang KJ; Guo X; Myers R; Ye Z; Zhang ZP; Li XF; Yang HS; Xing JL
Asian Pac J Cancer Prev; 2014; 15(17):7097-103. PubMed ID: 25227797
[TBL] [Abstract][Full Text] [Related]
12. High expression of monocarboxylate transporter 4 (MCT 4), but not MCT 1, predicts poor prognosis in patients with non-small cell lung cancer.
Tong YH; Hu XP; Xiang XP; Fang L
Transl Cancer Res; 2021 Mar; 10(3):1336-1345. PubMed ID: 35116459
[TBL] [Abstract][Full Text] [Related]
13. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.
Pértega-Gomes N; Vizcaíno JR; Miranda-Gonçalves V; Pinheiro C; Silva J; Pereira H; Monteiro P; Henrique RM; Reis RM; Lopes C; Baltazar F
BMC Cancer; 2011 Jul; 11():312. PubMed ID: 21787388
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients.
Wagner KW; Ye Y; Lin J; Vaporciyan AA; Roth JA; Wu X
Clin Cancer Res; 2012 Jan; 18(2):585-92. PubMed ID: 22252258
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
[TBL] [Abstract][Full Text] [Related]
16. A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.
Xu J; Yin Z; Shen H; Gao W; Qian Y; Pei D; Liu L; Shu Y
PLoS One; 2013; 8(11):e79135. PubMed ID: 24223174
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
[TBL] [Abstract][Full Text] [Related]
18. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.
Ma H; Chen J; Pan S; Dai J; Jin G; Hu Z; Shen H; Shu Y
Lung Cancer; 2011 Jul; 73(1):32-7. PubMed ID: 21145615
[TBL] [Abstract][Full Text] [Related]
19. MCT1 A1470T: a novel polymorphism for sprint performance?
Sawczuk M; Banting LK; Cięszczyk P; Maciejewska-Karłowska A; Zarębska A; Leońska-Duniec A; Jastrzębski Z; Bishop DJ; Eynon N
J Sci Med Sport; 2015 Jan; 18(1):114-8. PubMed ID: 24485392
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection.
Zhang Z; Ma F; Zhou F; Chen Y; Wang X; Zhang H; Zhu Y; Bi J; Zhang Y
Med Oncol; 2014 Dec; 31(12):179. PubMed ID: 25344870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
